losartan and 8-bromo cyclic adenosine monophosphate

losartan has been researched along with 8-bromo cyclic adenosine monophosphate in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hanehira, T; Kano, H; Kohno, M; Minami, M; Yasunari, K; Yokokawa, K; Yoshikawa, J1
Chatterjee, PK; Hawksworth, GM; McLay, JS; Mistry, SK; Weerackody, RP1

Other Studies

2 other study(ies) available for losartan and 8-bromo cyclic adenosine monophosphate

ArticleYear
Adrenomedullin is a potent inhibitor of angiotensin II-induced migration of human coronary artery smooth muscle cells.
    Hypertension (Dallas, Tex. : 1979), 1997, Volume: 29, Issue:6

    Topics: 8-Bromo Cyclic Adenosine Monophosphate; Adrenomedullin; Angiotensin II; Antihypertensive Agents; Biphenyl Compounds; Cell Movement; Cells, Cultured; Coronary Vessels; Dose-Response Relationship, Drug; Humans; Imidazoles; Losartan; Muscle, Smooth, Vascular; Peptides; Tetrazoles; Vasodilator Agents

1997
Selective antagonism of the AT1 receptor inhibits angiotensin II stimulated DNA and protein synthesis in primary cultures of human proximal tubular cells.
    Kidney international, 1997, Volume: 52, Issue:3

    Topics: 8-Bromo Cyclic Adenosine Monophosphate; Angiotensin II; Angiotensin Receptor Antagonists; Biphenyl Compounds; Cells, Cultured; DNA; Humans; Imidazoles; Kidney Tubules, Proximal; Losartan; Protein Biosynthesis; Pyridines; Tetrazoles

1997